Search results

• Ketamine
  ...August | pmid = 19391150 | doi = 10.1002/syn.20647}}</ref> as well as a [[dopamine reuptake inhibitor]].{{Citation needed|date=April 2010}} [[fr:Kétamine]]
  69 KB (9,697 words) - 21:01, 24 September 2010
• Fluoxetine
  ...eries for the ''[[in vitro]]'' reuptake of serotonin, norepinephrine and [[dopamine]]. This test, carried out by Jong-Sir Horng in May 1972,<ref name = Wong/> ...e neurotransmitters. 3 mg/kg increased only serotonin and did not increase dopamine and norepinephrine. The injection with 0.7 mg/kg fluoxetine corresponds to
  52 KB (7,168 words) - 16:47, 27 September 2010
• Promethazine
  ...eptors without blocking the secretion of histamine. It also is a very weak dopamine antagonist.<ref>David J. McCann and Brett Roth, [http://www.emedicine.com/E [[fr:Prométhazine]]
  10 KB (1,347 words) - 21:10, 12 September 2010
• Methyldopa
  ...lase]], which converts [[L-DOPA|<small>L</small>-DOPA]] into [[dopamine]]. Dopamine is a precursor for [[norepinephrine]] (noradrenaline) and subsequently [[ep * It is converted to [[α-methylnorepinephrine]] by [[dopamine beta-hydroxylase]] (DBH). α-methylnorepinephrine is an [[agonist]] of pres
  8 KB (905 words) - 10:56, 20 September 2010
• Dopamine
  |ImageFile2=Dopamine-3d-CPK.png ...cyclopedia.com/doc/1O87-ventraltegmentalarea.html Reference for VTA.</ref> Dopamine is also a [[neurohormone]] released by the [[hypothalamus]]. Its main funct
  48 KB (6,470 words) - 16:48, 27 September 2010
• Metoclopramide
  ...58:723–7. PMID 14186927.</ref> It appears to bind to [[dopamine receptor|dopamine D₂ receptors]] where it is a [[receptor antagonist]], and is als By inhibiting the action of [[dopamine]] ([[prolactin]]-inhibiting hormone), metoclopramide has sometimes been use
  11 KB (1,453 words) - 16:49, 27 September 2010
• Epinephrine
  ...rst oxidized to [[L-DOPA]], which is subsequently decarboxylated to give [[dopamine]]. Oxidation gives [[norepinephrine]], which is [[methylated]] to give epin ...ine precursors by enhancing the activity of [[tyrosine hydroxylase]] and [[dopamine-β-hydroxylase]], two key enzymes involved in catecholamine synthesis.{{Cit
  22 KB (2,916 words) - 16:50, 27 September 2010
• Nitrous oxide
  ...|author = Koyanagi S, Himukashi S, Mukaida K, Shichino T, Fukuda K|title = Dopamine D2-like receptor in the nucleus accumbens is involved in the antinociceptiv ...tle = Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitiz
  61 KB (8,728 words) - 16:50, 27 September 2010
• Ephedrine
  ...mode of therapeutic action involves norepinephrine and to a lesser degree dopamine, but it also releases some serotonin from presynaptic clefts. It should not [[fr:Éphédrine]]
  21 KB (2,906 words) - 16:51, 27 September 2010
• Diazepam
  ...odiazepine dependence: focus on withdrawal syndrome. | journal = Ann Pharm Fr | volume = 67 | issue = 6 | pages = 408–13 | month= November| year = 2009 ...| issue = 6 | pages = 479–85 | pmid = 15029082 | url = http://www.masson.fr/masson/portal/bookmark?Global=1&Page=18&MenuIdSelected=106&MenuItemSelected
  78 KB (10,295 words) - 16:51, 27 September 2010
• Cicuta
  ...29-2001}}</ref><ref name="Withers">{{cite journal |author=Withers LM, Cole FR, Nelson RB |title=Water-hemlock poisoning |journal=The New England Journal ...reated with intravenous [[fluid replacement]], but the administration of [[dopamine]] or [[norepinephrine]] may be required to restore blood pressure.<ref name
  29 KB (4,114 words) - 12:26, 7 July 2010
• Ergotamine
  ...and [[norepinephrine]] receptors. It is its action on the [[D2 receptor|D2 dopamine]] and [[5HT1A|5-HT_1A receptor]]s that can cause some side effect [[fr:Ergotamine]]
  7 KB (986 words) - 13:14, 20 September 2010
• Phenylpropanolamine
  ...e]], or as a [[norepinephrine releasing agent]] (NRA). It also acts as a [[dopamine releasing agent]] (DRA) to a lesser extent. [[fr:Phénylpropanolamine]]
  11 KB (1,420 words) - 13:15, 20 September 2010
• Hemoglobin
  ...de via autoxidation and/or monoamine oxidase (MAO)-mediated deamination of dopamine and the subsequent reaction of accessible ferrous iron to generate highly t [[fr:Hémoglobine]]
  67 KB (9,844 words) - 20:17, 21 September 2010
• Inotrope
  **[[Dopamine]] [[fr:Inotropisme]]
  3 KB (394 words) - 21:28, 21 September 2010
• Chronotropic
  *[[Dopamine]] [[fr:Chronotrope]]
  2 KB (228 words) - 21:28, 21 September 2010
• Nefopam
  ...Merlo-Pich E, Mennini T, Samanin R | title= Evidence of the involvement of dopamine in the analgesic effect of nefopam. | journal= European Journal of Pharmaco [[fr:Néfopam]]
  9 KB (1,159 words) - 22:06, 21 September 2010
• Cannabinoid
  *[[N-arachidonoyl-dopamine]] (NADA) ...known [[monoamine]] [[neurotransmitter]]s, such as [[acetylcholine]] and [[dopamine]], endocannabinoids differ in numerous ways from them. For instance, they u
  49 KB (6,487 words) - 22:06, 21 September 2010
• Endorphin
  ...released. By hijacking this process, exogenous opioids cause inappropriate dopamine release, and lead to aberrant [[synaptic plasticity]], which causes addicti ...runner's high; other candidates include [[epinephrine]], [[serotonin]], [[dopamine]] and more.
  18 KB (2,467 words) - 22:06, 21 September 2010
• Analgesic
  ...no anticholinergic properties and is believed be devoid of any activity on dopamine, serotonin or histamin receptors. It is not addictive and tolerance does no [[fr:Analgésique]]
  14 KB (1,807 words) - 22:06, 21 September 2010

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)